Sanara MedTech Statistics
Total Valuation
Sanara MedTech has a market cap or net worth of $275.88 million. The enterprise value is $299.91 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, before market open.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Sanara MedTech has 8.89 million shares outstanding. The number of shares has increased by 2.18% in one year.
| Current Share Class | 8.89M |
| Shares Outstanding | 8.89M |
| Shares Change (YoY) | +2.18% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 30.64% |
| Owned by Institutions (%) | 17.19% |
| Float | 3.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.89 |
| Forward PS | 3.37 |
| PB Ratio | 7.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.77, with a Debt / Equity ratio of 1.22.
| Current Ratio | 2.77 |
| Quick Ratio | 2.45 |
| Debt / Equity | 1.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.51 |
Financial Efficiency
Return on equity (ROE) is -29.22% and return on invested capital (ROIC) is -5.80%.
| Return on Equity (ROE) | -29.22% |
| Return on Assets (ROA) | -4.72% |
| Return on Invested Capital (ROIC) | -5.80% |
| Return on Capital Employed (ROCE) | -7.60% |
| Revenue Per Employee | $649,432 |
| Profits Per Employee | -$81,046 |
| Employee Count | 141 |
| Asset Turnover | 1.09 |
| Inventory Turnover | 2.19 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.49% in the last 52 weeks. The beta is 1.38, so Sanara MedTech's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | +0.49% |
| 50-Day Moving Average | 31.23 |
| 200-Day Moving Average | 32.99 |
| Relative Strength Index (RSI) | 47.04 |
| Average Volume (20 Days) | 25,257 |
Short Selling Information
The latest short interest is 209,577, so 2.36% of the outstanding shares have been sold short.
| Short Interest | 209,577 |
| Short Previous Month | 180,346 |
| Short % of Shares Out | 2.36% |
| Short % of Float | 5.80% |
| Short Ratio (days to cover) | 6.73 |
Income Statement
In the last 12 months, Sanara MedTech had revenue of $91.57 million and -$11.43 million in losses. Loss per share was -$1.34.
| Revenue | 91.57M |
| Gross Profit | 83.49M |
| Operating Income | -6.31M |
| Pretax Income | -4.89M |
| Net Income | -11.43M |
| EBITDA | -1.88M |
| EBIT | -6.31M |
| Loss Per Share | -$1.34 |
Full Income StatementBalance Sheet
The company has $20.69 million in cash and $44.72 million in debt, giving a net cash position of -$24.03 million or -$2.70 per share.
| Cash & Cash Equivalents | 20.69M |
| Total Debt | 44.72M |
| Net Cash | -24.03M |
| Net Cash Per Share | -$2.70 |
| Equity (Book Value) | 36.67M |
| Book Value Per Share | 4.12 |
| Working Capital | 23.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$428,298 and capital expenditures -$1.86 million, giving a free cash flow of -$2.29 million.
| Operating Cash Flow | -428,298 |
| Capital Expenditures | -1.86M |
| Free Cash Flow | -2.29M |
| FCF Per Share | -$0.26 |
Full Cash Flow StatementMargins
Gross margin is 91.17%, with operating and profit margins of -6.90% and -12.48%.
| Gross Margin | 91.17% |
| Operating Margin | -6.90% |
| Pretax Margin | -12.71% |
| Profit Margin | -12.48% |
| EBITDA Margin | -2.05% |
| EBIT Margin | -6.90% |
| FCF Margin | n/a |
Dividends & Yields
Sanara MedTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.18% |
| Shareholder Yield | -2.18% |
| Earnings Yield | -4.14% |
| FCF Yield | -0.83% |
Analyst Forecast
The average price target for Sanara MedTech is $49.50, which is 61.45% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $49.50 |
| Price Target Difference | 61.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on May 10, 2019. It was a reverse split with a ratio of 0.01:1.
| Last Split Date | May 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.01:1 |
Scores
Sanara MedTech has an Altman Z-Score of 3.28 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.28 |
| Piotroski F-Score | 4 |